Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T. Rowe Price Group | TROW | Jan 22, 2025 | 113.54 | -0.23 |
T. Rowe Price Growth Stock ETF | TGRW | Jan 22, 2025 | 41.20 | +1.83 |
T2 Biosystems | TTOO | Jan 22, 2025 | 0.23 | -0.30 |
Taboola.com | TBLA | Jan 22, 2025 | 3.63 | 0.00 |
Tactile Systems Technology | TCMD | Jan 22, 2025 | 17.38 | -2.08 |
Taitron Components A | TAIT | Jan 22, 2025 | 2.58 | 0.00 |
Taiwan Fund | TWN | Jan 22, 2025 | 39.10 | +1.93 |
Taiwan Index MSCI Ishares | EWT | Jan 22, 2025 | 53.35 | +0.45 |
Taiwan Semiconductor Manufacturing ADR | TSM | Jan 22, 2025 | 223.20 | +2.06 |
Take-Two Interactive Software | TTWO | Jan 22, 2025 | 187.99 | +1.54 |
Takeda Pharmaceutical ADR | TAK | Jan 22, 2025 | 12.89 | -1.60 |
TAL Education Group ADR | TAL | Jan 22, 2025 | 9.13 | -1.40 |
Talen Energy | TLN | Jan 22, 2025 | 249.99 | +2.61 |
Talkspace | TALK | Jan 22, 2025 | 3.16 | +0.64 |
Talos Energy | TALO | Jan 22, 2025 | 10.46 | -1.78 |
Talphera | TLPH | Jan 22, 2025 | 0.71 | +13.41 |
Tamboran Resources | TBN | Jan 22, 2025 | 21.51 | -0.09 |
Tandem Diabetes Care | TNDM | Jan 22, 2025 | 35.00 | -0.85 |
Tanger | SKT | Jan 22, 2025 | 32.65 | -1.45 |
Tango Therapeutics | TNGX | Jan 22, 2025 | 3.08 | 0.00 |
Tantech | TANH | Jan 22, 2025 | 0.16 | +0.25 |
Taoping | TAOP | Jan 22, 2025 | 0.32 | -0.75 |
Tapestry | TPR | Jan 22, 2025 | 73.34 | -0.96 |
Targa Resources | TRGP | Jan 22, 2025 | 211.27 | -2.74 |
Target | TGT | Jan 22, 2025 | 135.77 | -1.14 |
Target Hospitality | TH | Jan 22, 2025 | 10.17 | +0.59 |
Tarsus Pharmaceuticals | TARS | Jan 22, 2025 | 48.11 | +2.93 |
Taseko Mines | TGB | Jan 22, 2025 | 1.96 | -2.49 |
TaskUs A | TASK | Jan 22, 2025 | 16.93 | -0.18 |
TAT Technologies | TATT | Jan 22, 2025 | 30.80 | +1.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.